Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
N Engl J Med
; 388(23): 2145-2158, 2023 06 08.
Article
in En
| MEDLINE
| ID: mdl-36972026
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Endometrial Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Female
/
Humans
Language:
En
Journal:
N Engl J Med
Year:
2023
Type:
Article